Technology News and Research

RSS

Parata Systems, Pharmacy Times launch The Next-Generation Pharmacist Program

Parata Systems and Pharmacy Times have joined forces to salute pharmacy professionals who are defining the future of pharmacy by launching The Next-Generation Pharmacist Program.

24 Mar 2010

Bone stem cells could become a part of new, innovative hip replacement treatment

Bone stem cells could in future be used instead of bone from donors as part of an innovative new hip replacement treatment, according to scientists at the University of Southampton.

24 Mar 2010

Bergen research group adopts nanotechnology for cancer research

Professor James Lorens and his team at the University of Bergen's Department of Biomedicine are using nanotechnology to study how to make cells form new blood vessels, both within the patient's body and in the laboratory. In the next phase the team will use this knowledge to investigate the molecular mechanisms that govern the progression of cancer.

24 Mar 2010

RCOG prostate cancer treatment database reaches new milestone

Radiotherapy Centers of Georgia (RCOG), a division of RC Cancer Centers announced today that they have reached a new milestone and recently treated their 12,500th patient for prostate cancer with their ProstRcision® treatment therapy.

24 Mar 2010

Elderly patients with moderate sleep apnea live longer than their counterparts, says study

Findings from the Technion-Israel Institute of Technology could provide good news for elderly patients who suffer from sleep apnea. The research results from Prof. Peretz Lavie and Dr. Lena Lavie of the Faculty of Medicine show that elderly patients with moderate sleep apnea live longer than their counterparts in the general population.

24 Mar 2010

Life Technologies' real-time PCR instrument available for IVD use in Europe

Life Technologies Corporation (NASDAQ: LIFE) today announced that its Applied Biosystems 7500 Fast Dx Real-Time PCR Instrument is available as a platform suitable for in vitro diagnostics (IVD) use in Europe. Clinical laboratories from 22 countries and European institutions that develop in vitro molecular diagnostic assays in oncology, genetic disease and infectious disease will now be able to leverage the instrument’s regulatory clearance to develop tests for clinical applications.

24 Mar 2010

British couples seek alternative fertility treatment in the US

With strict social and legal restrictions associated with third party reproduction, as well as limited egg donors available in the UK, an increasing number of British couples are traveling to the U.S. for alternative fertility treatments, such as egg donation. Unfortunately, the UK does not allow financial compensation for egg donors; this greatly reduces the number of available donors and presents major obstacles for many infertile couples, some of whom wait for an egg donor for two years or longer. Last year approximately 1200 egg donors were needed in the UK, and roughly 500 families were unable to find a donor.

24 Mar 2010

Ambry Genetics introduces a suite of genetic tests to pinpoint the cause of mental retardation

Ambry Genetics today introduced The Ambry X-Linked Mental Retardation SuperPANEL™, a suite of genetic tests expected to pinpoint the cause of intellectual disability and X-linked mental retardation (XLMR).

24 Mar 2010

GENETICS 2010 meeting highlights latest research on human genetic disorders

The Genetics Society of America (GSA) biennial meeting, "GENETICS 2010: Model Organisms to Human Biology," June 12-15, 2010, at the Sheraton Boston, Massachusetts, will bring together investigators who study genetic models in organisms such as flies, yeast, fungi, mice and other non-human organisms, with researchers in human genetics

24 Mar 2010

Bioheart to open five centers to provide cell therapy procedures for congestive heart failure patients

Bioheart, Inc., announced today plans for establishing five Centers of Excellence in Latin America to provide its cell therapy procedures to patients suffering from congestive heart failure and peripheral arterial disease beginning next month, April 2010. Bioheart entered into its first agreement with a leading treatment facilitator, Regenerative Medicine Institute of Tijuana, Mexico. Therapies for CHF and PAD patients will be made available at the Hospital Angeles Tijuana, a fully equipped state-of–the-art private specialties hospital. This will be the first of five Centers of Excellence with four additional Centers to be announced in the coming months.

24 Mar 2010

High-density genotyping array launched to study complexity of mouse genetics

Affymetrix, Inc. and The Jackson Laboratory today announced the full commercial launch of the Affymetrix® Mouse Diversity Genotyping Array. This is the first high-density genotyping array that enables researchers to study the complexity of the mouse genome and the diversity among mouse strains.

24 Mar 2010

UC engineering researchers create tiny pools with programmable microfluidic systems

As just published as the cover story in "Lab on a Chip," in "Virtual electrowetting channels: electronic liquid transport with continuous channel functionality," engineering researchers at the University of Cincinnati have created a paradigm shift - and moved some tiny channels in the process.

24 Mar 2010

Opinion: Repurposing wastewater; expanding global fund; financing global health needs

In an Economic Times opinion piece, Jeffrey Sachs of the Earth Institute at Columbia University outlines what he sees as "two huge challenges facing" the Global Fund to Fight AIDS, Tuberculosis and Malaria:

24 Mar 2010

Nephros and STERIS to develop filtration-based products for medical device applications

Nephros, Inc., a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today reported that is has entered into a development agreement with STERIS Corporation.

24 Mar 2010

Bioalliance Pharma's anti-emetic drug Setofilm receives European approval

BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced approval for Setofilm® in 16 European countries.

24 Mar 2010

Virginia-based medical practice implements CTT's pain therapy medical device

Competitive Technologies, Inc. announced that a premier physician oncology practice based in Virginia has begun using CTT's Calmare® Therapy pain therapy medical device to treat patients suffering from pain related to cancer, under the direction of several medical oncologists.

24 Mar 2010

Medical imaging benefits outweigh radiation risks, says ESC

Cardiac nuclear imaging and computed tomography angiography (CCTA) still have an important role to play in cardiac disease diagnosis, say experts from the European Society of Cardiology (ESC).

24 Mar 2010

New breakthrough technology makes it easier to investigate brain physiology

Thanks to new technology developed by researchers in Lund, it has for the first time become possible to measure blood flow in the brain directly and continuously.

24 Mar 2010

HPV test could help predict risk of cervical cancer, but more research needed

Testing for the human papillomavirus (HPV) - the major cause of cervical cancer - may not help to identify women who are at risk of the disease, a new UK study suggests.

24 Mar 2010

Pluristem Therapeutics receives European Patent on core 3D cell expansion technology

Pluristem Therapeutics Inc. today announced that it has been granted a European Patent on its core 3D cell expansion technology. The granting of the European patent follows the issuance of several corresponding US patents as well as corresponding patents in ten additional jurisdictions.

23 Mar 2010

Technology News and Research

Parata Systems, Pharmacy Times launch The Next-Generation Pharmacist Program

Bone stem cells could become a part of new, innovative hip replacement treatment

Bergen research group adopts nanotechnology for cancer research

RCOG prostate cancer treatment database reaches new milestone

Elderly patients with moderate sleep apnea live longer than their counterparts, says study

Life Technologies' real-time PCR instrument available for IVD use in Europe

British couples seek alternative fertility treatment in the US

Ambry Genetics introduces a suite of genetic tests to pinpoint the cause of mental retardation

GENETICS 2010 meeting highlights latest research on human genetic disorders

Bioheart to open five centers to provide cell therapy procedures for congestive heart failure patients

High-density genotyping array launched to study complexity of mouse genetics

UC engineering researchers create tiny pools with programmable microfluidic systems

Opinion: Repurposing wastewater; expanding global fund; financing global health needs

Nephros and STERIS to develop filtration-based products for medical device applications

Bioalliance Pharma's anti-emetic drug Setofilm receives European approval

Virginia-based medical practice implements CTT's pain therapy medical device

Medical imaging benefits outweigh radiation risks, says ESC

New breakthrough technology makes it easier to investigate brain physiology

HPV test could help predict risk of cervical cancer, but more research needed

Pluristem Therapeutics receives European Patent on core 3D cell expansion technology

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News